Cargando…

Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients

BACKGROUND: Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandsma, Joost, Chenoweth, Josh G., Gregory, Melissa K., Krishnan, Subramaniam, Blair, Paul W., Striegel, Deborah A., Mehta, Rittal, Schully, Kevin L., Dumler, J. Stephen, Sikorski, CDR Cynthia S., O’Connor, Kelsey, Reichert-Scrivner, Susan A., Paguirigan, Carmen M., Uyehara, Catherine F. T., Ngauy, COL Viseth, Myers, Christopher A., Clark, Danielle V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365123/
https://www.ncbi.nlm.nih.gov/pubmed/35947596
http://dx.doi.org/10.1371/journal.pone.0272572
_version_ 1784765275402403840
author Brandsma, Joost
Chenoweth, Josh G.
Gregory, Melissa K.
Krishnan, Subramaniam
Blair, Paul W.
Striegel, Deborah A.
Mehta, Rittal
Schully, Kevin L.
Dumler, J. Stephen
Sikorski, CDR Cynthia S.
O’Connor, Kelsey
Reichert-Scrivner, Susan A.
Paguirigan, Carmen M.
Uyehara, Catherine F. T.
Ngauy, COL Viseth
Myers, Christopher A.
Clark, Danielle V.
author_facet Brandsma, Joost
Chenoweth, Josh G.
Gregory, Melissa K.
Krishnan, Subramaniam
Blair, Paul W.
Striegel, Deborah A.
Mehta, Rittal
Schully, Kevin L.
Dumler, J. Stephen
Sikorski, CDR Cynthia S.
O’Connor, Kelsey
Reichert-Scrivner, Susan A.
Paguirigan, Carmen M.
Uyehara, Catherine F. T.
Ngauy, COL Viseth
Myers, Christopher A.
Clark, Danielle V.
author_sort Brandsma, Joost
collection PubMed
description BACKGROUND: Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift phlebotomy closer to the point of care, supporting telemedicine strategies and virtual clinical trials. Here we assess a capillary blood micro-sampling device, the Tasso Serum Separator Tube (SST), for measuring blood protein levels in healthy subjects and non-hospitalized COVID-19 patients. METHODS: 57 healthy controls and 56 participants with mild/moderate COVID-19 were recruited at two U.S. military healthcare facilities. Healthy controls donated Tasso SST capillary serum, venous plasma and venous serum samples at multiple time points, while COVID-19 patients donated a single Tasso SST serum sample at enrolment. Concentrations of 17 protein inflammatory biomarkers were measured in all biospecimens by Ella multi-analyte immune-assay. RESULTS: Tasso SST serum protein measurements in healthy control subjects were highly reproducible, but their agreements with matched venous samples varied. Most of the selected proteins, including CRP, Ferritin, IL-6 and PCT, were well-correlated between Tasso SST and venous serum with little sample type bias, but concentrations of D-dimer, IL-1B and IL-1Ra were not. Self-collection at home with delayed sample processing was associated with significant concentrations differences for several analytes compared to supervised, in-clinic collection with rapid processing. Finally, Tasso SST serum protein concentrations were significantly elevated in in non-hospitalized COVID-19 patients compared with healthy controls. CONCLUSIONS: Self-collection of capillary blood with micro-sampling devices provides an attractive alternative to routine phlebotomy. However, concentrations of certain analytes may differ significantly from those in venous samples, and factors including user proficiency, temperature control and time lags between specimen collection and processing need to be considered for their effect on sample quality and reproducibility.
format Online
Article
Text
id pubmed-9365123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93651232022-08-11 Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients Brandsma, Joost Chenoweth, Josh G. Gregory, Melissa K. Krishnan, Subramaniam Blair, Paul W. Striegel, Deborah A. Mehta, Rittal Schully, Kevin L. Dumler, J. Stephen Sikorski, CDR Cynthia S. O’Connor, Kelsey Reichert-Scrivner, Susan A. Paguirigan, Carmen M. Uyehara, Catherine F. T. Ngauy, COL Viseth Myers, Christopher A. Clark, Danielle V. PLoS One Research Article BACKGROUND: Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift phlebotomy closer to the point of care, supporting telemedicine strategies and virtual clinical trials. Here we assess a capillary blood micro-sampling device, the Tasso Serum Separator Tube (SST), for measuring blood protein levels in healthy subjects and non-hospitalized COVID-19 patients. METHODS: 57 healthy controls and 56 participants with mild/moderate COVID-19 were recruited at two U.S. military healthcare facilities. Healthy controls donated Tasso SST capillary serum, venous plasma and venous serum samples at multiple time points, while COVID-19 patients donated a single Tasso SST serum sample at enrolment. Concentrations of 17 protein inflammatory biomarkers were measured in all biospecimens by Ella multi-analyte immune-assay. RESULTS: Tasso SST serum protein measurements in healthy control subjects were highly reproducible, but their agreements with matched venous samples varied. Most of the selected proteins, including CRP, Ferritin, IL-6 and PCT, were well-correlated between Tasso SST and venous serum with little sample type bias, but concentrations of D-dimer, IL-1B and IL-1Ra were not. Self-collection at home with delayed sample processing was associated with significant concentrations differences for several analytes compared to supervised, in-clinic collection with rapid processing. Finally, Tasso SST serum protein concentrations were significantly elevated in in non-hospitalized COVID-19 patients compared with healthy controls. CONCLUSIONS: Self-collection of capillary blood with micro-sampling devices provides an attractive alternative to routine phlebotomy. However, concentrations of certain analytes may differ significantly from those in venous samples, and factors including user proficiency, temperature control and time lags between specimen collection and processing need to be considered for their effect on sample quality and reproducibility. Public Library of Science 2022-08-10 /pmc/articles/PMC9365123/ /pubmed/35947596 http://dx.doi.org/10.1371/journal.pone.0272572 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Brandsma, Joost
Chenoweth, Josh G.
Gregory, Melissa K.
Krishnan, Subramaniam
Blair, Paul W.
Striegel, Deborah A.
Mehta, Rittal
Schully, Kevin L.
Dumler, J. Stephen
Sikorski, CDR Cynthia S.
O’Connor, Kelsey
Reichert-Scrivner, Susan A.
Paguirigan, Carmen M.
Uyehara, Catherine F. T.
Ngauy, COL Viseth
Myers, Christopher A.
Clark, Danielle V.
Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title_full Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title_fullStr Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title_full_unstemmed Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title_short Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients
title_sort assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and covid-19 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365123/
https://www.ncbi.nlm.nih.gov/pubmed/35947596
http://dx.doi.org/10.1371/journal.pone.0272572
work_keys_str_mv AT brandsmajoost assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT chenowethjoshg assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT gregorymelissak assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT krishnansubramaniam assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT blairpaulw assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT striegeldeboraha assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT mehtarittal assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT schullykevinl assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT dumlerjstephen assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT sikorskicdrcynthias assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT oconnorkelsey assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT reichertscrivnersusana assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT paguirigancarmenm assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT uyeharacatherineft assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT ngauycolviseth assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT myerschristophera assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients
AT clarkdaniellev assessingtheuseofamicrosamplingdeviceformeasuringbloodproteinlevelsinhealthysubjectsandcovid19patients